The Food and Drug Administration (FDA) approved AstraZeneca's tremelimumab in combination with durvalumab and platinum-based chemotherapy for adult patients with...
Lung Cancer
On August 10, 2022, the Food and Drug Administration granted regular approval to capmatinib (Tabrecta) for adult patients with metastatic...
Lung cancer is a malignant lung tumor. It is considered the most common type of cancer in men and the third...
In September, the FDA approved 2 new medications in the oncology & hematology category. Pralsetinib was approved for adult patients...
